Home » Topics » Hematologic, BioWorld Science

Hematologic, BioWorld Science
RSS

Antiplatelet and antithrombotic effects of NSL-9403

Nov. 28, 1997

FACT study results reported

Nov. 27, 1997

Expanded use approved for ReoPro in Europe

Nov. 26, 1997

NDA filed in U.S. for Otsuka antiplatelet agent

Nov. 26, 1997

Agrylin approved in Canada

Nov. 25, 1997

Lilly claims antithrombotic diamides

Nov. 24, 1997

FDA clears Plavix

Nov. 19, 1997

Prodrugs of thrombin inhibitors prepared at BMS

Nov. 18, 1997

Clinical safety and pharmacology of Vasoflux

Nov. 14, 1997

VM-201 preclinical data presented at AHA meeting

Nov. 14, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 27, 2026.
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...
Emerging therapeutic strategies for Parkinson’s at ADPD 2026
BioWorld
Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 24, 2026
SERCA inhibitor shows promise for MSA-C treatment
BioWorld Science
At the ongoing International Conference on Alzheimer’s and Parkinson’s Diseases and Related Neurological Disorders (AD/PD 2026) in Copenhagen, researchers...